FDA Approved: SABRIL — Original Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Sabril (vigabatrin) from Lundbeck as an original NDA for the treatment of infantile spasms and refractory complex partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Infantile Spasms

Drugs mentioned

• SABRIL (VIGABATRIN)

Snippet

ORIG AP for SABRIL (VIGABATRIN)